Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Entero Therapeutics Inc (ENTO)

Entero Therapeutics Inc (ENTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,749
  • Shares Outstanding, K 1,588
  • Annual Sales, $ 0 K
  • Annual Income, $ -18,060 K
  • EBIT $ -3 M
  • EBITDA $ -3 M
  • 60-Month Beta 1.19
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.27
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.69
  • Most Recent Earnings $-0.64 on 11/19/25
  • Next Earnings Date 04/07/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.40 +24.58%
on 11/21/25
4.57 -34.54%
on 10/29/25
-0.96 (-24.30%)
since 10/28/25
3-Month
1.97 +51.78%
on 08/29/25
5.84 -48.80%
on 10/15/25
+0.84 (+39.07%)
since 08/28/25
52-Week
0.97 +208.47%
on 04/30/25
5.84 -48.80%
on 10/15/25
+1.63 (+119.29%)
since 11/27/24

Most Recent Stories

More News
Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX"

BOCA RATON, FL / ACCESS Newswire / November 28, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) (the "Company") today announced that it will change its name to GridAI Technologies Corp., effective at 12:01...

ENTO : 2.99 (+5.28%)
ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer

BOCA RATON, FLORIDA / ACCESS Newswire / November 19, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) ("Entero" or the "Company") today announced that its subsidiary Grid AI has executed a Letter of Intent...

ENTO : 2.99 (+5.28%)
Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy

Timed with a sharp acceleration in AI-data-center expansion, with more than $60B in new projects announced in the last 90 days.

ENTO : 2.99 (+5.28%)
Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid

Integration boosts Grid AI's deployment capacity as AI data-center power demand approaches 50 GW, growing by over 165% through 2030i

ENTO : 2.99 (+5.28%)
Entero Regains Nasdaq Compliance With Grid AI Acquisition

BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics, Inc. ("Entero" or the "Company") (NASDAQ:ENTO) is pleased to announce that, as a result of the acquisition of 100% of Grid AI...

ENTO : 2.99 (+5.28%)
Entero Therapeutics, Inc., Launches Grid AI Corp to Redefine How AI Infrastructure Connects to the Power Grid

BOCA RATON, FL / ACCESS Newswire / October 16, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) ("ENTO" or the "Company") a company pioneering innovation at the intersection of biotechnology and AI-driven...

ENTO : 2.99 (+5.28%)
Entero Therapeutics Acquires GRID AI Corp for Expansion

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update...

ENTO : 2.99 (+5.28%)
ENTERO THERAPEUTICS (ENTO) Enters $100 Billion+ AI and Data Center Market with Acquisition of GRID AI

Transaction positions ENTO in the high-growth AI energy-infrastructure market, amid a surge of multi-billion-dollar hyperscaler spending on data centers, and rapid growth in behind-the-meter energy storage...

ENTO : 2.99 (+5.28%)
ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand

Transaction positions ENTO in the high-growth AI energy-infrastructure market, amid a surge of multi-billion-dollar hyperscaler spending on data centers, and rapid growth in behind-the-meter energy storage...

ENTO : 2.99 (+5.28%)
Entero Therapeutics, Inc. Announces Reverse Stock Split

Boca Raton, Florida--(Newsfile Corp. - August 14, 2025) - Entero Therapeutics, Inc. (NASDAQ: ENTO) (the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted,...

ENTO : 2.99 (+5.28%)

Business Summary

Entero Therapeutics Inc. is a late clinical-stage biopharmaceutical company. It focused on the development of targeted, non-systemic therapies for gastrointestinal diseases. Entero Therapeutics Inc., formerly known as First Wave BioPharma Inc., is based in BOCA RATON, Fla.

See More

Key Turning Points

3rd Resistance Point 4.46
2nd Resistance Point 4.10
1st Resistance Point 3.55
Last Price 2.99
1st Support Level 2.64
2nd Support Level 2.28
3rd Support Level 1.73

See More

52-Week High 5.84
Fibonacci 61.8% 3.98
Fibonacci 50% 3.40
Last Price 2.99
Fibonacci 38.2% 2.83
52-Week Low 0.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar